Factors influencing SARS-CoV-2 antibody formation Einflussfaktoren auf die SARS-CoV-2 Antikörper Bildung
Latest Information Update: 12 Mar 2024
At a glance
- Drugs Ad26.COV2 S (Primary) ; AZD 1222 (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
Most Recent Events
- 08 Mar 2024 Status changed to completed.
- 08 Feb 2024 New trial record